H A Jinnah Selected Research

Stroke (Strokes)

2/2019	A Scale to Assess Activities of Daily Living in Pantothenate Kinase-Associated Neurodegeneration.
10/2007	Serum uric acid and brain ischemia in normal elderly adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H A Jinnah Research Topics

Disease

36	Dystonia (Limb Dystonia) 04/2024 - 05/2000
34	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 03/2024 - 04/2000
7	Hyperuricemia 01/2020 - 10/2000
6	Torticollis (Wryneck) 04/2024 - 12/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019 - 06/2001
4	Blepharospasm 04/2024 - 03/2001
4	Dystonic Disorders (Writer's Cramp) 04/2024 - 06/2013
4	Nervous System Diseases (Neurological Disorders) 01/2024 - 10/2002
4	Parkinsonian Disorders (Parkinsonism) 01/2023 - 07/2010
4	Parkinson Disease (Parkinson's Disease) 01/2023 - 07/2009
4	Neurodevelopmental Disorders 03/2022 - 05/2007
4	Dystonia musculorum deformans type 1 01/2022 - 10/2012
4	Nephrolithiasis 08/2014 - 03/2009
4	Neuroblastoma 07/2014 - 05/2007
3	Pain (Aches) 01/2019 - 10/2002
3	Cognitive Dysfunction 01/2016 - 01/2007
3	Gouty Arthritis 08/2014 - 03/2009
3	Channelopathies 02/2013 - 09/2002
3	Chorea (Rheumatic Chorea) 01/2008 - 09/2002
2	Dopa-responsive Dystonia 01/2023 - 01/2021
2	Movement Disorders (Movement Disorder) 01/2023 - 09/2002
2	Tremor (Tremors) 06/2020 - 02/2008
2	Neurologic Manifestations (Neurological Manifestations) 01/2020 - 07/2009
2	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 12/2019 - 02/2019
2	Stroke (Strokes) 02/2019 - 10/2007
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 03/2008
2	Atrophy 10/2012 - 06/2001
2	Gout 04/2012 - 07/2009
2	Inborn Genetic Diseases (Disease, Hereditary) 08/2009 - 11/2001
2	Brain Ischemia (Cerebral Ischemia) 12/2008 - 10/2007
2	Phenylketonurias (Phenylketonuria) 01/2004 - 12/2001
2	Dyskinesias (Dyskinesia) 10/2002 - 09/2002
1	Anxiety Disorders (Anxiety Disorder) 10/2023
1	Hemifacial Spasm 10/2023
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2021
1	Spasm (Spasms) 11/2020
1	Aphasia (Dysphasia) 02/2019
1	Heart Failure 01/2019
1	Deglutition Disorders (Dysphagia) 01/2018
1	Dysphonia (Spastic Dysphonia) 02/2017
1	Task-Specific Focal Dystonia 01/2017

Drug/Important Bio-Agent (IBA)

30	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2024 - 04/2000
22	EnzymesIBA 01/2024 - 04/2000
19	purineIBA 01/2021 - 04/2000
13	Uric Acid (Urate)IBA 11/2022 - 05/2006
12	Dopamine (Intropin)FDA LinkGeneric 03/2024 - 02/2002
6	HypoxanthineIBA 03/2022 - 02/2002
6	GuanineIBA 03/2022 - 02/2002
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2001
5	Botulinum Toxins (Botulinum Toxin)IBA 02/2024 - 06/2016
5	TransferasesIBA 03/2022 - 02/2002
4	Calcium Channels (Calcium Channel)IBA 01/2019 - 10/2002
3	Levodopa (L Dopa)FDA LinkGeneric 03/2024 - 12/2017
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2023 - 12/2017
3	CalciumIBA 01/2019 - 09/2002
3	Ion Channels (Ion Channel)IBA 02/2013 - 10/2002
3	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2006 - 05/2000
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2023 - 01/2018
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022 - 01/2019
2	Cholinergic Agents (Cholinergics)IBA 01/2022 - 01/2019
2	Trihexyphenidyl (Artane)FDA LinkGeneric 01/2022 - 01/2019
2	IronIBA 12/2019 - 12/2015
2	ecopipamIBA 04/2016 - 01/2016
2	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 04/2016 - 01/2016
2	Nerve Growth Factor (NGF)IBA 04/2015 - 12/2013
2	Codon (Codons)IBA 06/2013 - 10/2012
2	Ethanol (Ethyl Alcohol)IBA 02/2013 - 10/2002
2	Caffeine (No Doz)FDA LinkGeneric 02/2013 - 10/2002
2	Kainic Acid (Kainate)IBA 09/2008 - 09/2002
2	AntioxidantsIBA 10/2007 - 01/2007
2	FPL 64176IBA 11/2003 - 05/2000
2	Methyl ester 1,4- dihydro- 2,6- dimethyl- 5- nitro- 4- (2- (trifluoromethyl)phenyl)- 3-Pyridinecarboxylic acidIBA 11/2003 - 05/2000
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	6- fluoro- 2- (4- (pyridin- 2- yl)but- 3- yn- 1- yl)imidazo(1,2- a)pyridineIBA 02/2024
1	PurinesIBA 01/2024
1	insulin receptor-related receptor (IRR)IBA 10/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2023
1	RacloprideIBA 01/2023
1	Dopamine AntagonistsIBA 01/2023
1	2- methyl- 4- carboxy- 5- hydroxy- 3,4,5,6- tetrahydropyrimidineIBA 01/2022
1	Muscarinic M4 ReceptorIBA 01/2022
1	Carisoprodol (Soma)FDA LinkGeneric 12/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	AICA ribonucleotide (ZMP)IBA 01/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019
1	AMP Deaminase (Myoadenylate Deaminase)IBA 01/2019
1	Dihydroxyphenylalanine (Dopa)IBA 01/2019
1	Heavy MetalsIBA 01/2019
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019
1	Opiate AlkaloidsIBA 04/2018
1	abobotulinumtoxinA FDA Link 01/2018
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2018

Therapy/Procedure

13	Therapeutics 10/2023 - 07/2005
6	Deep Brain Stimulation 01/2023 - 11/2014
3	Activities of Daily Living (ADL) 02/2019 - 12/2014
1	Electrodes (Electrode) 11/2020
1	Operative Surgical Procedures 01/2019
1	Injections 02/2017